Histone deacetylase 8 in focus: Decoding structural prerequisites for innovative epigenetic intervention beyond...

Area of Science:

• Biochemistry
• Epigenetics
• Medicinal Chemistry

Background:

• Histone deacetylase 8 (HDAC8) inhibitors are crucial for epigenetic regulation.
• Non-hydroxamate HDAC8 inhibitors (HDAC8is) show promise, offering selectivity and potentially fewer toxic side effects compared to hydroxamate-based HDAC8is.
• Hydroxamate HDAC8is can lack specificity and exhibit unfavorable toxicity, driving the need for alternative inhibitors.

Purpose of the Study:

• To identify the critical structural requirements for potent non-hydroxamate HDAC8 inhibitors.
• To explore the molecular basis of HDAC8 inhibition by non-hydroxamate compounds.
• To provide insights for the rational design of novel HDAC8-targeted therapies.

Main Methods:

• Quantitative Structure-Activity Relationship (QSAR) analysis using Bayesian classification and Recursive partitioning on 866 compounds.
• Machine learning methods to pinpoint essential structural features.
• Molecular docking and molecular dynamic (MD) simulations to validate and understand structural insights.

Main Results:

• Key structural motifs essential for potent HDAC8 inhibitory activity were identified.
• The study elucidated the molecular interactions governing non-hydroxamate HDAC8 inhibition.
• QSAR models effectively predicted inhibitory activity based on structural features.

Conclusions:

• Non-hydroxamate compounds possess significant potential as selective HDAC8 inhibitors.
• Understanding structural requirements facilitates the development of safer and more effective epigenetic therapies.
• This research provides a foundation for designing novel therapeutics targeting HDAC8 for various diseases.